ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

IINN Inspira Technologies Oxy B H N Ltd

2,20
-0,01 (-0,45%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:50:09
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Inspira Technologies Oxy B H N Ltd IINN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,45% 2,20 01:50:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,20 1,91 2,20 2,09 2,21
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202415:18PRNUSInspira™ Announces Start of Production of the INSPIRA™..
25.4.202414:00PRNUSInspira™ Receives CSA Certification of Compliance to U.S...
16.4.202414:42PRNUSInspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device..
10.4.202414:24PRNUSInspira™ and Ennocure In Vitro Study Results Show 100%..
03.4.202414:30PRNUSInspira™ Announces Program to Pioneer the Applicable Use of..
01.4.202414:00PRNUSInspira™ Announces $1.65 Million Registered Direct Offering..
25.3.202414:20PRNUSInspira™ Technologies Reports Full Year 2023 Financial..
18.3.202412:00PRNUSInspira™ Announces AMAR Regulatory Submission of the..
12.3.202413:00PRNUSInspira™ Releases New Data Demonstrating Superiority of its..
08.3.202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.3.202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.3.202415:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.3.202415:20PRNUSInspira™ Announces Plans to Report the Primary Results for a..
27.2.202413:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.2.202413:02PRNUSInspira™ To Host Conference Call to Discuss Investor..
27.2.202413:00PRNUSInspira™ Announces Breakthrough Update: Nears First FDA..
22.2.202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.2.202413:00PRNUSInspira™ introduces high-end platform for bio-mimicking..
14.2.202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.2.202413:30PRNUSInspira™ Receives First Ever U.S. Patent Approval for an..
12.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202415:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.2.202415:00PRNUSInspira™ Technologies Collaborates with a Leading Israeli..
30.1.202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202414:30PRNUSInspira™ Technologies Signs Strategic Agreement to Enter..
09.1.202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09.1.202414:30PRNUSInspira™ Announces Plans to Launch and Target Single-Use..
02.1.202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.1.202414:30PRNUSInspira™ Technologies Signs Letter of Intent with..
28.12.202322:01PRNUSInspira™ Technologies Closes on $3.88 Million Registered..
28.12.202315:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.12.202322:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.12.202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.12.202320:16PRNUSInspira Announces $3.88 Million Registered Direct Offering
26.12.202314:45PRNUSInspira™ Announces 95% Accuracy Results for HYLA™ Blood..
18.12.202314:30PRNUSInspira Technologies to Participate in J.P. Morgan..
11.12.202315:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.12.202315:00PRNUSIn Preparation for FDA Clearance and Device Deployment,..
29.11.202315:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.11.202315:02PRNUSInspira Collaborates with Ennocure for development of a..
22.11.202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.11.202315:40PRNUSInspira™ Technologies Reports Third Quarter 2023 Financial..
16.11.202315:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.11.202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.11.202313:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.11.202315:02PRNUSInspira™ Announces Israeli Innovation Authority Grant for..
25.10.202322:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25.10.202314:30PRNUSInspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical..
25.10.202313:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock